Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Schubert

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Journal of Neurochemistry|December 29, 2015
Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicityClemens Falker, Alexander Hartmann, Inga Guett, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2020
Hallmarks of <i>Alpha</i>- and <i>Betacoronavirus</i> non-structural protein 7+8 complexesBoris Krichel, Ganesh Bylapudi, Christina Schmidt, et al.
Science Advances|March 4, 2021
Hallmarks of <i>Alpha-</i> and <i>Betacoronavirus</i> non-structural protein 7+8 complexesBoris Krichel, Ganesh Bylapudi, Christina Schmidt, et al.
Frontiers in Neurology|August 3, 2023
LASSI-L detects early cognitive changes in pre-motor manifest Huntington's disease: a replication and validation studyLuis A Sierra, Shelby B Hughes, Clementina J Ullman, et al.
Physical Therapy|May 19, 2019
Physical Activity and Exercise Outcomes in Huntington Disease (PACE-HD): Protocol for a 12-Month Trial Within Cohort Evaluation of a Physical Activity Intervention in People With Huntington DiseaseCheney J G Drew, Lori Quinn, Katy Hamana, et al.
Journal of Neuroscience Methods|December 15, 2015
Neuroimaging of a minipig model of Huntington's disease: Feasibility of volumetric, diffusion-weighted and spectroscopic assessmentsRobin Schubert, Frauke Frank, Nina Nagelmann, et al.
The Lancet. Neurology|December 20, 2018
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging studyRalf Reilmann, Andrew McGarry, Igor D Grachev, et al.
Parkinsonism & Related Disorders|July 9, 2022
Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's diseaseLori Quinn, Rebecca Playle, Cheney J G Drew, et al.
Brain Communications|January 2, 2025
The joint memory effect: challenging the selfish stigma in Huntington's disease?Romain Dalléry, Nicolas Fraisse, Laurent Cléret de Langavant, et al.
Plos One|August 23, 2021
Cognitive decline in Huntington's disease in the Digitalized Arithmetic Task (DAT)Marine Lunven, Jennifer Hamet Bagnou, Katia Youssov, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Journal of Neurochemistry|December 29, 2015
Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicityClemens Falker, Alexander Hartmann, Inga Guett, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2020
Hallmarks of <i>Alpha</i>- and <i>Betacoronavirus</i> non-structural protein 7+8 complexesBoris Krichel, Ganesh Bylapudi, Christina Schmidt, et al.
Science Advances|March 4, 2021
Hallmarks of <i>Alpha-</i> and <i>Betacoronavirus</i> non-structural protein 7+8 complexesBoris Krichel, Ganesh Bylapudi, Christina Schmidt, et al.
Frontiers in Neurology|August 3, 2023
LASSI-L detects early cognitive changes in pre-motor manifest Huntington's disease: a replication and validation studyLuis A Sierra, Shelby B Hughes, Clementina J Ullman, et al.
Physical Therapy|May 19, 2019
Physical Activity and Exercise Outcomes in Huntington Disease (PACE-HD): Protocol for a 12-Month Trial Within Cohort Evaluation of a Physical Activity Intervention in People With Huntington DiseaseCheney J G Drew, Lori Quinn, Katy Hamana, et al.
Journal of Neuroscience Methods|December 15, 2015
Neuroimaging of a minipig model of Huntington's disease: Feasibility of volumetric, diffusion-weighted and spectroscopic assessmentsRobin Schubert, Frauke Frank, Nina Nagelmann, et al.
The Lancet. Neurology|December 20, 2018
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging studyRalf Reilmann, Andrew McGarry, Igor D Grachev, et al.
Parkinsonism & Related Disorders|July 9, 2022
Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's diseaseLori Quinn, Rebecca Playle, Cheney J G Drew, et al.
Brain Communications|January 2, 2025
The joint memory effect: challenging the selfish stigma in Huntington's disease?Romain Dalléry, Nicolas Fraisse, Laurent Cléret de Langavant, et al.
Plos One|August 23, 2021
Cognitive decline in Huntington's disease in the Digitalized Arithmetic Task (DAT)Marine Lunven, Jennifer Hamet Bagnou, Katia Youssov, et al.
Pageof 8